​Join us to meet our latest batch of companies enabling the next wave of drug discovery and development. Our Showcase will offer you a chance to see the exciting work the 12 teams from our current cohort.

​​During this showcase, attendees will have the chance to hear from our latest teams, engage with the leaders of these ventures, gain insights into their methods & solutions, and explore the potential impact of their work on biopharma and beyond. At the end of the day, please join us for an excellent sunset reception high above Manhattan while enjoying some victuals and refreshments with friends new and familiar.

​​We're excited to bring together a community of individuals passionate about what the future could hold. Don't miss this chance to connect with pioneers at the forefront of digital innovation and to be among the first to learn about the next big breakthroughs. We look forward to welcoming you to what promises to be a fruitful and thought-provoking showcase.

​Agenda

• ​3:30p - Check-in Opens

• ​4:00p - Welcome

• ​4:05p - Enabling Biology: building novel methods for designing the next generation of therapeutics

• ​4:35p - Coffee Break

• ​4:45p - Redefining Human Disease: providing insights that promise to reshape our understanding of human disease

• ​5:15p - Coffee Break

• ​5:25p - AI Toolkits for R&D Teams: the next generation of software tools that enable R&D teams to focus on what matters most

• ​5:55p - Closeout

• ​6:00p - Reception Begins

• ​8:30p - Reception Ends

​About the Merck Digital Sciences Studio

​The Merck Digital Sciences Studio is a collaboration between Merck and the New Jersey Innovation Institute (NJII), a New Jersey Institute of Technology corporation, with investments from the Merck Global Health Innovation Fund, Northpond Ventures and McKesson Ventures. Technology support is provided by Microsoft for Startups.

​About McDermott Will & Emery

​McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

​Photo & Video Release

​Please be advised that attendance to this event is considered as consent for photos and videos to be taken of all in attendance which may be used in publications, news releases, online, or other communications or media regarding the MDS Studio.

​Cohort 3 Teams Presenting

​Augment Biologics: Using foundational discoveries in glycobiology to transform biologic drug development

​Esya Labs: Making brain health screening as routine and accessible as any other essential health check

​Hebbian Bio: Unlocking novel treatments and biomarkers for neuro conditions through precision medicine

​ImYoo: Powering personalized medicine via big molecular data directly from patients

​Inaedis: Manufacturing thermally stable biologics and vaccines

​ModernVivo: Helping scientists design optimized in vivo models to accelerate timelines and identify effective therapeutics

​Nine Diagnostics: Determining treatment effectiveness and discovering new biology

​Orb Therapeutics: Creating the first programmable platform to advance transformative therapies for patients

​Potato: Building an AI scientist to speed up discovery

​ReSync Bio: Serving as a single source of truth for preclinical operations: coordinating labs, data, and software programs on one platform

​UbiquiTx: Integrating AI, computation, and biological automation to accelerate the design of novel proteome editors

​Voyant Bio: Designing precision immunotherapies targeting immune-immune cell interactions to radically improve cancer patient treatment outcomes